[1] World Health Organization,2016-2021年全球卫生部门病毒性肝炎战略[EB/OL].(2016-06).https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/zh/. [2] World Health Organization,2016-2021年全球卫生部门艾滋病毒战略[EB/OL].(2016-06).https://www.who.int/hiv/strategy2016-2021/GHSS_HIV_CH_08012016.pdf?ua=1. [3] BUSCH M P,BLOCH E M,KLEINMAN S.Prevention of transfusion-transmitted infections[J].Blood,2019,133(17):1854-1864. [4] 程金凤,焦巍,周红霞,等.术前/输血前患者乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒核酸检测多中心研究[J].临床输血与检验,2020,22(6):568-573. [5] 董航,黄雪原,贺理,等.多中心HBV、HCV、HIV血清学检测弱反应性标本的核酸检测结果分析[J].临床输血与检验,2020,22(6):579-583. [6] MARTINOT-PEIGNOUX M,ASSELAH T,MARCELL IN P.HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients[J].Liver Int,2014,35:82-90. [7] TORBENSON M,THOMAS D L.Occult hepatitis B[J].Lancet Infect Dis,2002,2(8):479-486. [8] WHO guidelines on hepatitis B and C testing[M].Geneva:World Health Organization,2017:70-76. [9] Centers for Disease Control and Prevention (CDC).Testing for HCV Infection:An Update of Guidance for Clinicians and Laboratorians[J].MMWR Morb Mortal Wkly Rep,2013,62(18):362-365. [10] 中国疾病预防控制中心.全国艾滋病检测技术规范(2020年修订版)[S].北京,中国疾病预防控制中心:2020. [11] 董莉娟,陈会超,杨朝军,等.HIV-1 WB试验不确定样本的HIV-1 RNA定量检测结果分析[J].中国艾滋病性病,2017,23(6):550-552. [12] 佚名.EIA筛查抗HIV重复阳性献血者中RIBA实验和HIV核酸检测的对比研究[J].中国输血杂志,2001(S1):135. |